Jasper Therapeutics (JSPR) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

JSPR Jasper Therapeutics

Watchlist

23.090
-0.530-2.24%

Close Dec 4 16:00 ET

23.090
0.0000.00%

Post 20:01 ET

346.38MMarket Cap-4861P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | Jasper Therapeutics Inc - Initial Data Expected in Second Half of 2025
ReutersDec 2 16:30 ET
Express News | Jasper Therapeutics Announces First Patient Dosed in Phase 1B/2a Etesian Clinical Study of Briquilimab in Asthma
ReutersDec 2 16:30 ET
Jasper Therapeutics Announces First Patient Dosed in Phase 1b/2a ETESIAN Clinical Study of Briquilimab in Asthma
Jasper TherapeuticsDec 2 00:00 ET
We're Keeping An Eye On Jasper Therapeutics' (NASDAQ:JSPR) Cash Burn Rate
Yahoo FinanceNov 16 09:33 ET
Is Jasper Therapeutics (NASDAQ:JSPR) In A Good Position To Deliver On Growth Plans?
Simply Wall StNov 16 08:09 ET
Is Jasper Therapeutics (JSPR) the Best Multibagger Stock to Buy Heading Into 2025?
Yahoo FinanceNov 16 01:35 ET

Comments

Kamacho09

Oct 16 07:23

$Jasper Therapeutics (JSPR.US)$ 80??

Teo knows

Oct 14 07:35

$Jasper Therapeutics (JSPR.US)$ good time to hop in

Stock_Drift

Oct 14 07:09

Pre Market Ticks. 8:07am 10/14

$Destiny Tech100 (DXYZ.US)$ $Vanda Pharmaceuticals (VNDA.US)$ $In8bio (INAB.US)$ $Rani Therapeutics (RANI.US)$ $Jasper Therapeutics (JSPR.US)$ $B Riley Financial Inc 7.5% Sr Nts 31/05/2027 Usd25 (RILYZ.US)$ $B. Riley Financial Inc (RILYP.US)$ $B Riley Financial Inc 6.375% Senior Notes Due 2025 (RILYM.US)$ $B. Riley Financial (RILY.US)$ $Longboard Pharmaceuticals(Delisted) (LBPH.US)$ $Expion360 (XPON.US)$ $Inventiva (IVA.US)$ $Tevogen Bio Holdings (TVGN.US)$

Jaguar8

Oct 14 06:57

NEWS

$Jasper Therapeutics (JSPR.US)$
Jasper Therapeutics Reports Positive Data from SPOTLIGHT Study of Briquilimab in Chronic Inducible Urticaria
14 of 15 participants enrolled achieved a clinical response
10 of 12 participants in the 120mg cohort achieved a complete response
No serious adverse events; no grade 3 or higher adverse events reported
Initial data from BEACON study expected week of January 6th, 2025, including 180mg Q8W cohort
Company to host conference call and webinar today at 8:00 ...